Page last updated: 2024-08-05 11:38:38

organonitrogen heterocyclic antibiotic

null

ChEBI ID: 25558

Members (6)

MemberDefinitionRole
anisomycinAn antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.(-)-anisomycin
cycloserineA 4-amino-1,2-oxazolidin-3-one that has R configuration. It is an antibiotic produced by Streptomyces garyphalus or S. orchidaceus and is used as part of a multi-drug regimen for the treatment of tuberculosis when resistance to, or toxicity from, primary drugs has developed. An analogue of D-alanine, it interferes with bacterial cell wall synthesis in the cytoplasm by competitive inhibition of L-alanine racemase (which forms D-alanine from L-alanine) and D-alanine--D-alanine ligase (which incorporates D-alanine into the pentapeptide required for peptidoglycan formation and bacterial cell wall synthesis).D-cycloserine zwitterion; D-cycloserine
cystothiazole aAn organonitrogen heterocyclic antibiotic that is 2,4'-bi-1,3-thiazole substituted by an isopropyl group at position 2' and a 3,5,7-trimethoxy-4-methyl-7-oxohepta-1,5-dien-1-yl group at position 4 (the 2E,4R,5S,6E stereoisomer). It is isolated from the culture broth of myxobacterium, Cystobacter fuscus, and exhibits antifungal and cytotoxic activity.cystothiazole A
flomoxefA second-generation oxacephem antibiotic in which the oxazine ring is substituted at C-3 with a hydroxyethyl-substituted tetrazolylthiomethyl group and the azetidinone ring carries 7alpha-methoxy and 7beta-{2-[(difluoromethyl)thiomethyl]acetamido} substituents.flomoxef
nifurtoinolAn imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group and at position 3 by a hydroxymethyl group.nifurtoinol
nitrofurantoinAn imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA.nitrofurantoin

Research

Studies (6,571)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19903,386 (51.53)18.7374
1990's728 (11.08)18.2507
2000's1,004 (15.28)29.6817
2010's1,121 (17.06)24.3611
2020's332 (5.05)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials380 (5.38%)5.53%
Reviews366 (5.18%)6.00%
Case Studies389 (5.51%)4.05%
Observational8 (0.11%)0.25%
Other5,917 (83.81%)84.16%